Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological Adverse Events and Improve Quality of Life

NCT03263052 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT03263052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03263052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological Adverse Events and Improve Quality of Life
Lead sponsor
University of Illinois at Chicago
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
January 1, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to renal transplantation